ClinicalTrials.Veeva

Menu

Quality-of-Life-and-Cognitive-Oriented Rehabilitation Through the NeuronUP in Alzheimer's Disease

U

Universidad Rey Juan Carlos

Status

Completed

Conditions

Older People
Alzheimer Disease
Cognitive Impairment
Occupational Therapy
Quality of Life

Treatments

Procedure: Conventional occupational therapy sessions
Procedure: Conventional occupational therapy sessions + NeuronUP

Study type

Interventional

Funder types

Other

Identifiers

NCT06499272
271120234112023

Details and patient eligibility

About

Introduction: New technologies are a support in the rehabilitation of users. The therapeutic approach to cognitive rehabilitation encompasses a variety of techniques, among which traditional occupational therapy stands out. This modality includes a series of interventions such as cognitive stimulation through the use of cards, functional activities, psychomotor exercises, the application of sensory stimuli and the incorporation of music therapy. An additional alternative is to integrate a cognitive stimulation program such as NeuronUP, which is a computerized tool. This integration can increase adherence to treatment and contribute to preserving or improving the individual's cognitive functioning and improving quality of life.

Objective: The objective established for this study was to verify whether the combination of occupational therapy with the NeuronUP computer program improves or maintains the cognitive status and quality of life of users with Alzheimer's disease. In addition, to determine whether the use of this program leads to greater adherence to treatment by patients.

Material and methods: This is a randomized clinical trial. Participants' cognitive status will be assessed using the MEC (Mini Cognitive Examination) tool, cognitive skills using the LOTCA (Loewenstein Occupational Therapy Cognitive Assessment), and perceived quality of life using the Whoqol-Bref questionnaire. At the end of treatment, the CSQ-8, a tool designed to determine the degree of user satisfaction, will be administered.

Enrollment

35 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult men or women, aged 65 years or olde.
  • Not present severe cognitive impairment, measured through the Mini Cognitive Examination test (MEC>22 points).
  • To reside permanently in the Nursing Home.
  • Attend Occupational Therapy sessions regularly.
  • Have adequate manual dexterity to be able to use a Tablet.
  • Agree to participate voluntarily in the study.

Exclusion criteria

  • Having severe cognitive impairment, as measured by the Mini Cognitive Examination (MEC<22 points).
  • Having comorbid diagnoses such as stroke, brain tumours or heart disease, among others.
  • Not attending Occupational Therapy sessions regularly.
  • Poor adherence to the treatments offered at the centre.
  • Not agreeing to participate voluntarily in the study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

35 participants in 2 patient groups

Experimental Group (EG)
Experimental group
Description:
Experimental Group (EG), which received therapy with NeuronUP, plus their conventional occupational therapy sessions.
Treatment:
Procedure: Conventional occupational therapy sessions + NeuronUP
Control Group (CG
Active Comparator group
Description:
Control Group (CG), which received their usual sessions of conventional occupational therapy.
Treatment:
Procedure: Conventional occupational therapy sessions

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems